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Abstract 
Rearrangements of T-cell receptor (TCR) genes are 
characteristic chromosomal abnormalities in a 
variety of T-cell malignancies, particularly in T-cell 
lymphoblastic leukemia/lymphomas, but TCR-
gamma gene or TCL1A (TCR-T-cell 
leukemia/lymphoma 1A) rearrangements are rare. 
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Clinics and pathology 
Disease 
T-cell acute lymphoblastic leukemia/lymphoblastic 
lymphoma (T-ALL); rarely: acute myeloid 
leukemia (AML). 
Table 1. Clinical findings of patients with t(7;14)(p15;q32). Abbreviations: AML-M2, Acute myeloblastic  leukemia with 
maturation; AML-M4, Acute myelomonocytic leukemia; BAL, Bilineage or biphenotypic leukemia; T-ALL, T-Acute  lymphoblastic 
leukemia/lymphoblastic lymphoma; MT/NKN, Mature T- and NK-cell neoplasm. 
1-2. Kaneko et al., 1989; 3. Raimondi et al., 1989; 4. Teramura et al., 1989; 5-6. Pui et al., 1991; 7. Toyoda et al., 1991; 8-9. 
Heerema et al., 1998;  10.Strehl et al.,  2001; 11. Chang et al., 2006; 12. Xu et al., 2009; 13. Gill et al., 2011; 14. Narayan et al., 
2013; 15. Sugimoto et al., 2014. 
Phenotype/cell stem origin 
An immature thymocytic pattern: CD7-positive, 
surface CD3-negative and CD4/CD8- negative. 
Etiology 
T-cell acute lymphoblastic leukemia/lymphoblastic 
lymphoma in 11  (Kaneko et al., 1989; Teramura et 
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al., 1989; Pui et al., 1991; Toyoda et al., 1991; 
Heerema et al., 1998; Chang et al., 2006; Gill et al., 
2011; Sugimoto et al., 2014), among them 1 with 
human immunodeficiency virus infection (Gill et 
al., 2011). Additional cases included: 1 mature T- 
and NK-cell neoplasm (Narayan et al., 2013), 2 
AML  (Raimondi et al., 1989; Strehl et al., 2001) 
and 1 biphenotypic leukemia ( BAL) (Xu et al., 
2009). 
Epidemiology 
15 patients (9 males and 6 females) aged 4 to 55 
years (median 14 years); mainly pediatric cases (12 
out of 15 patients; aged 4 to 16 years). 
Prognosis 
6 of the described patients achieved clinical 
remission after therapy and had a favorable 
outcome with survival of 1 to 24+ months (Data 
from Sugimoto et al., 2014). 
Cytogenetics 
Note 
Because precise breakpoints are often difficult to 
define, it is possible that the reported 
t(7;14)(p15;q32) involve various 7p14-7p15.1-
p15.3 breakpoints and dispersion of breakpoints 
throughout the 14q32.1-32.3 region involving 
various genes. 
Cytogenetics morphological 
Sole anomaly in 6 T-Acute lymphoblastic 
leukemia/lymphoblastic lymphoma  (Teramura et 
al., 1989; Pui et al., 1991; Toyoda et al., 1991; Gill 
et al., 2011; Narayan et al., 2013; Sugimoto et al., 
2014) and in both AML patients (Raimondi et al., 
1989;  Strehl et al., 2001); found in association with 
5q deletion in 1 (Heerema et al., 1998) and  12p 
anomalies in 4 (Kaneko et al., 1989; Pui et al., 
1991; Chang et al., 2006). 
Genes involved and 
proteins 
TRG (T-cell receptor gamma) 
Location 
7p14.1 
Note 
Belongs to the family of T-cell receptor genes 
encoding T-cell receptor gamma chains, previously 
often described as located at band 7p14-p15. Note 
that the breakpoint has been described at 7p15 in a 
case with TRG+ (Sugimoto et al., 2014). 
HOXA@  (homeo box A cluster) 
Location 
7p15.2 
Protein 
HOXA cluster genes at 7p15 act as transcription 
factors regulating gene expression, morphogenesis, 
and differentiation. Chromosomal disruption of 
HOXA genes by chromosomal rearrangements such 
as inv(7)(p15q34) or t(7;7)(p15;q34) that involve 
TRB at 7q34 and t(7;14)(p15;q11) that disrupt TRD 
at 14q11 results in HOXA upregulation and ectopic 
expression in T-cell acute lymphoblastic 
leukemia/lymphoma, indicating important role for 
HOXA genes in T-ALL. 
TCL1A (T-cell leukemia/lymphoma 
1A) 
Location 
14q32.1 
Protein 
TCL1A located on 14q32.1 and TCL1B located 
centromeric of TCL1A belong to the TCL1 family 
of genes known to be affected by chromosomal 
rearrangements in T-cell leukemia/lymphoma. 
TCL1 is a target of chromosomal translocations 
t(14;14)(q11;q32.1) or t(7;14)(q35;q32.1) and 
inversions inv(14)(q11q32.1) involving the T- cell 
receptor alpha /delta locus at 14q11 and TCR beta 
loci at 14q35 leading to its deregulation in T-cell 
leukemias, such as T-prolymphocytic leukemia. It 
is also activated in preleukemic clonal cells and 
chronic leukemias arising in cases of 
immunodeficiency syndromes such as ataxia-
telangiectasia as a consequence of chromosome 
translocation involving TRA/TRD locus. TCL1 
functions as a coactivator in a PI3-kinase dependent 
Akt pro-survival pathway. 
Result of the chromosomal 
anomaly 
Fusion protein 
Oncogenesis 
The chromosomal translocation t(7;14)(p15;q32) is 
associated with T-cell acute leukemia/lymphoma 
mainly, indicating the abnormality may involve 
genes casually implicated in the development of 
these types of malignancies. Found often as a sole 
anomaly or in association with limited additional 
rearrangements in the majority of reported patients, 
thus probably involved in the initiation of 
malignancy. The fusion of TCL1A/TCL1B and 
TRG genes was confirmed by FISH in 1 patient 
(Sugimoto et al., 2014), indicating that activation of 
TCL1 by its juxtaposition to regulatory elements of 
T-cell receptor gene leading to TCL1 
overexpression is involved in leukemogenesis. 
However, in the remaining patients the genes 
involved are unknown and probable various genes 
have been implicated. It is possible that in some 
patients, the abnormality may involve other genes 
such as HOXA genes identified in 7p15 region and 
t(7;14)(p15;q32) Zamecnikova A 
 
 
 
 
 
Atlas Genet Cytogenet Oncol Haematol. 2019; 23(1) 31 
 
TCL1B (TML1) and TCL6 (TNG1, or TNG2) that 
are overexpressed in T-cell leukemias with 14q32.1 
rearrangements. 
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